Rachel K. King Glycomimetics Inc (GLYC) insider trading activity

Rachel K. King is of GLYCOMIMETICS INC. Currently has a direct ownership of 515,194 shares of GLYC, which is worth approximately $170,014. The most recent transaction as insider was on Mar 29, 2024, when has been sold 3,334 shares (Common Stock) at a price of $3.0 per share, resulting in proceeds of $10,002. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 515K

0.65% 3M change

13.9% 12M change

Total Value Held $170,014

Rachel K. King Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 29 2024	BUY Grant, award, or other acquisition	$10,002 $3.0 p/Share	3,334 Added 0.64%	515,194 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$10,001 $2.36 p/Share	4,238 Added 0.82%	511,860 Common Stock
Sep 30 2023	BUY Grant, award, or other acquisition	$10,000 $1.5 p/Share	6,667 Added 1.3%	507,622 Common Stock
Jan 20 2021	BUY Grant, award, or other acquisition	-	96,250 Added 17.55%	452,314 Common Stock
Dec 28 2020	SELL Open market or private sale	$329,128 $3.91 p/Share	84,176 Reduced 19.12%	356,064 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$146,520 $1.12 p/Share	130,821 Added 22.91%	440,240 Common Stock

Also insider at

NVAX

NOVAVAX INC Healthcare

RKK

Rachel K. King

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLYC shares.

Notify only if

Value

Insider Trading

Get notified when an Glycomimetics Inc insider buys or sells GLYC shares.

Notify only if

Operation

Value

Type

News

Receive news related to GLYCOMIMETICS INC

Track Activities on GLYC

Account